Archive for September, 2012

INTERACT! @StanfordMedX

interact_header-graphic

Medicine X is a conference designed to engage all stakeholders to improve healthcare at the intersection of emerging technologies. The Stanford AIM lab has created a series of new technologies and online challenges designed to ignite interaction between guests using our unique QR-coded badges that are tied to our Medicine X website. In order to participate, all you need is a mobile device that can surf the web and read QR codes. Most smartphones (e.g. iPhone and Android) and tablet devices such as the iPad will work.

Continue Reading →

Announcing the Medicine X Wellness Room

wellness_room

Last May, after a wonderful (and exhausting) day at Denise Silber’s Doctors 2.0 & You conference in Paris, our Medicine X group decamped to Royal Madeleine to recuperate. Our dinner discussion raised a few questions. Why are conferences so exhausting?  Wouldn’t it be nice to take a nap if you are tired or jet-lagged, yet still not miss the sessions you want to see?

Continue Reading →

Announcing the Stanford Medicine X Global Access Program

conference_for_everyone_blog_photo

Medicine X is an academic conference designed for everyone. As part of that inclusive mission, we’ve created special programs designed to encourage ePatients, academic scholars and students to participate in the conference. Now I am proud to announce our Global Access Program, which will allow anyone who can’t join us at Stanford to attend virtually through a high-quality streaming webcast. And the price to view the webcast is one that anyone can afford: it’s free.

Continue Reading →

Esther Dyson: angel investor, health nut

Esther Dyson banner image

When angel investor Esther Dyson was in Russia, training for a private space flight, she was struck by how rigorously we track the health of astronauts. In the earthbound world, of course, it’s only sick among us who accrue detailed medical records.

“I came back, and I thought: Let’s genoytpe all the astronauts,” recalls Dyson, who sits on the board of the Silicon Valley personal genomics company 23andMe. Exploring the genetic makeup of an unusually healthy population seemed like an irresistible research opportunity. Continue Reading →